Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome.
Ghaith Abu-ZeinahSilvana Di GiandomenicoDaniel C ChoiTatiana CruzKatie ErdosElwood TaylorEllen K RitchieRichard T SilverJoseph Michael ScanduraPublished in: Blood advances (2022)